Trials / Completed
CompletedNCT02084992
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
A Multicenter Randomized Controlled Evaluation of Heart Failure Disease Management Using Advanced Telecommunications Within a Diverse Provider Network: The Specialized Primary and Networked Care in HF (SPAN-CHF) III Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 212 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will randomize participants with a diagnosis of congestive heart failure and at least one risk factor for hospitalization to either a tablet computer and web based disease management program or a telephone based disease management program. Both interventions are home based with heart failure education and symptom monitoring provided by nurse managers. The nurse managers are in close communication with both the participants and the participants' physicians . The components of the disease management program have been developed at Tufts Medical Center and the New England Quality Care Alliance with studies showing improved clinical outcomes, including reduced hospitalizations. The goal of this study is to transition this successful home monitoring and disease management program to a tablet computer and web-based implementation to both improve clinical outcomes (reducing hospitalizations and improving self-perceived health status) and improve provider-patient satisfaction. We hypothesize that the tablet computer based disease management will decrease heart failure hospitalizations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Expanded technology disease management | Tablet computers loaded with a web-based disease management program will be given to patients for the duration of the study. |
| OTHER | Telephonic disease management |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2014-03-12
- Last updated
- 2019-10-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02084992. Inclusion in this directory is not an endorsement.